Postexposure prophylaxis
Knowledge regarding postexposure prophylaxis of HIV among nurses
... Abstract: Fifty nurses working in BP Koirala Memorial Cancer Hospital, Bharatpur, were selected by probability simple random sampling technique for determining the knowledge level about postexposure ...
6
Recombinant Protective Antigen Anthrax Vaccine Improves Survival when Administered as a Postexposure Prophylaxis Countermeasure with Antibiotic in the New Zealand White Rabbit Model of Inhalation Anthrax
... B acillus anthracis is a naturally occurring, spore-forming bacte- rium that can cause different forms of human disease depend- ing on the route of exposure. Inhalation anthrax is the most lethal form, with mortality ...
7
Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis
... ABSTRACT Vaccine-induced B cells differentiate along two pathways. The follicular pathway gives rise to germinal centers (GCs) that can take weeks to fully develop. The extrafollicular pathway gives rise to short-lived ...
13
Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody
... 31). Postexposure prophylaxis with KZ52 at 1 h postchallenge resulted in an order of magnitude reduction of plasma viremia (mean of ...posure prophylaxis at 6 h after challenge did not affect plasma ...
5
Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)
... Postexposure prophylaxis (PEP) after intravaginal exposure to human immunodeficiency virus (HIV) was investigated using the HIV type 2 (HIV-2)/pig-tailed macaque transmission ...
5
Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus
... for postexposure prophylaxis (PEP) for occu- pational and nonoccupational (eg, sexual, needle-shar- ing) exposures to HIV have been published by the US Public Health Service, but they do not directly ...
17
Evaluation of Immunogenicity and Efficacy of Anthrax Vaccine Adsorbed for Postexposure Prophylaxis
... administered postexposure can reduce the incidence or progression of anthrax disease, but they do not protect against the disease resulting from the germination of spores that may remain in the body after ...
11
Human Immunodeficiency Virus Postexposure Prophylaxis for Adolescents and Children
... therapy can be stratified by exposure type and cir- cumstances. HIV PEP should only be provided in the context of intensive HIV reduction counseling and overseen by providers knowledgeable of antiretrovi- ral medications ...
15
Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis
... Blocking ELISA reaction between human monoclonal antibodies and polioviruses Blocking activity % with antigen of typea: 1 MAb against type 1 poliovirus were the only ones that reacted wi[r] ...
9
Postexposure Prophylaxis of Varicella in Family Contact by Oral Acyclovir
... Varicella-zoster virus DNA sequences amplified by the nested polymerase chain reaction (PCR) in peripheral blood mononuclear cells of children who were exposed to the virus in their fami[r] ...
6
HIV AIDS Health Care Maintenance and Disease Prevention
... Health care personnel (HCP) and other individuals working in medical, public safety, sanitation, and laboratory settings are at risk of occupational exposure to HIV. Although avoiding exposure to HIV is the only reliable ...
74
Interactions of monoclonal antibodies with an influenza A virus
... The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.. Ig[r] ...
310
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
... anthrax postexposure prophylaxis and treatment, recommending that antitoxin should be added to antibiotic therapy for any patient suspected of a systemic anthrax ...
6
Postexposure Prevention of Progressive Vaccinia in SCID Mice Treated with Vaccinia Immune Globulin
... In postexposure prophylaxis studies, early postexposure treat- ment was given at 10 mg/mouse/dose on days 2, 5, 10, and 15 after vaccinia virus ...
8
Reinvestigating the Role of IgM in Rabies Virus Postexposure Vaccination
... B cells secreting IgG antibodies, but not IgM, are thought to be solely responsible for vaccine-induced protection against rabies virus (RABV) infections in postexposure settings. In this report, we reinvestigated ...
6
VENOUS THROMBOEMBOLISM PROPHYLAXIS IN MEDICAL INPATIENTS AND ADHERENCE TO GUIDELINE RECOMMENDATIONS: A PROSPECTIVE STUDY
... VTE prophylaxis is not properly addressed in medical inpatients in our ...pharmacological prophylaxis (especially in low- risk patients) which leads to substantial economic burden on the health care ...
7
Tafenoquine and its potential in the treatment and relapse prevention of <em>Plasmodium vivax</em> malaria: the evidence to date
... drug targeting the hepatic stages of primary schizonts and secondary schizonts (hypnozoites) would be critical for causal prophylaxis, terminal prophylaxis/presumptive anti- rela[r] ...
13
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
... Primary prophylaxis with clotting factor concentrates started early in childhood prevents joint bleeds, thus avoiding joint damage and improving people’s quality of ...primary prophylaxis worldwide mainly ...
7
Effectiveness of Antiemetics in the Management of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Following Chemotherapy Guidelines
... and refractory. Acute CINV starts during the first 24 h, usually within the first few minutes to hours after the administration of chemotherapy. Delayed CINV develops in patients 24 h after the administration of ...
9
The Use of Systemic Fluoroquinolones
... included prophylaxis during periods of neutropenia; empiric therapy in febrile, neutropenic children with cancer; treatment of patients with multidrug-resistant Gram-negative bacillary septicemia or meningitis; ...
8